Sun Pharma announced strong third quarter results. Sales rose 15% to Rs 15,469 crore and net profit climbed 16% to Rs 3,368 crore. Growth was fueled by its branded businesses in India and emerging markets, along with global innovative medicines. The company also declared an interim dividend.
